Keyphrases
Liver
100%
Weight Loss
100%
Sodium-glucose Cotransporter
100%
Neurocircuitry
100%
Tofogliflozin
80%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
60%
Anti-obesity
60%
Adipocyte
40%
Protein Kinase
40%
Sham
40%
Glycogen Depletion
40%
Fat Mass
20%
High-fat Diet
20%
Adipose Tissue
20%
White Adipose Tissue
20%
Lipolysis
20%
Antidiabetic
20%
Highly Selective
20%
Diet-induced Obese Mice
20%
Protein Phosphorylation
20%
Sham Operation
20%
Hepatic Glycogen
20%
Hepatic Vagotomy
20%
Protein Kinase A Pathway
20%
Triglyceride Lipase
20%
Medicine and Dentistry
Adipose Tissue
100%
Sodium Glucose Cotransporter 2
100%
Tofogliflozin
66%
Cyclic AMP Dependent Protein Kinase
50%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Adipocyte
33%
Triacylglycerol
16%
Diet Induced Obesity
16%
White Adipose Tissue
16%
Protein Phosphorylation
16%
Triacylglycerol Lipase
16%
Sham Procedure
16%
Antidiabetic Agent
16%
Lipolysis
16%
Vagotomy
16%
High Fat Food
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tofogliflozin
100%
Sodium Glucose Cotransporter 2
100%
Cyclic AMP Dependent Protein Kinase
75%
Sodium Glucose Cotransporter 2 Inhibitor
75%
Triacylglycerol
25%
Pancreatic Lipase
25%
Diet Induced Obesity
25%
Antidiabetic Agent
25%